Search

Ying Ying Jiang

from Flushing, NY
Age ~48

Ying Jiang Phones & Addresses

  • 43 158Th St, Flushing, NY 10451 (718) 463-0039
  • Brooklyn, NY
  • 43 158Th St, Bronx, NY 10451 (718) 463-0039
  • Katy, TX
  • Nashville, TN

Professional Records

Lawyers & Attorneys

Ying Jiang Photo 1

Ying Jiang - Lawyer

View page
Licenses:
New York - Currently registered 2012
Education:
Washington University IN St. Louis
Ying Jiang Photo 2

Ying Jiang

License Records

Ying Jiang

License #:
C7-0006265 - Active
Category:
Medical Practice
Type:
ACGME Training

Real Estate Brokers

Ying Jiang Photo 3

Ying Jiang, Houston TX Agent

View page
Work:
T & L properties
Houston, TX
(832) 247-9228 (Phone)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Ying Jiang
Everboom Shi Long Moving Co
Movers
2109 Venables St, Vancouver, BC V5L2J3
Ying Jiang
Everboom Shi Long Moving Company
Movers
1642 Pender St E, Vancouver, BC V5L1W3
Ying Jiang
AVENUE P GROCERY INC
382 Ave P, Brooklyn, NY 11204
2461 84 St, Brooklyn, NY 11214
Ying Jiang
Everboom Shi Long Moving Company
Movers
Ying Hong Jiang
FOREST PARK FIRST WOK, INC
Ying Z. Jiang
JIANG ASSET GROUP, LLC
Ying Z. Jiang
JIANG PROPERTY, LLC
Ying Z. Jiang
JIANG FAMILY GROUP, LLC

Publications

Us Patents

G-Protein Coupled Receptor Ligands And Methods

View page
US Patent:
7338772, Mar 4, 2008
Filed:
Apr 10, 2003
Appl. No.:
10/411545
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566
US Classification:
435 721, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

G-Protein Coupled Receptor Ligands And Methods

View page
US Patent:
7807390, Oct 5, 2010
Filed:
Jan 7, 2008
Appl. No.:
11/970276
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33/566
C07K 14/705
US Classification:
435 721, 435 71, 435 72, 436501
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Antibodies And Functional Fragments Thereof That Specifically Bind An Rf-Amide Peptide Or A Precursor Thereof

View page
US Patent:
8133980, Mar 13, 2012
Filed:
Oct 1, 2010
Appl. No.:
12/896297
Inventors:
Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07K 16/00
C12P 21/08
US Classification:
5303879, 5303881, 53038815, 4241391
Abstract:
The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Cell-Based High-Throughput Screening Methods

View page
US Patent:
20040253647, Dec 16, 2004
Filed:
Aug 6, 2004
Appl. No.:
10/481954
Inventors:
Paul Mathews - Irvington-on-Hudson NY, US
Ralph Nixon - Tarrytown NY, US
Stephen Schmidt - Nutley NJ, US
Ying Jiang - Valhalla NY, US
International Classification:
G01N033/53
G01N033/567
US Classification:
435/007200
Abstract:
The present invention describes cell-based screening methods that allow for the elimination of false-positive results due to nonspecific toxicity of test compounds, while detecting those compounds that specifically modulate cellular metabolites in metabolic pathways associated with diseases and disorders, with particular regard to Alzheimer's disease. The methods are particularly suited to high-throughput screening techniques to identify compounds (drugs) that are effective in a cell-based system. The methods of the invention involve determining within a cell system the levels of both a metabolic precursor and a metabolite of interest and have broad application in high-throughput drug discovery and identification, particularly for precursor and metabolite molecules which are associated with disease and disease progression, such as Alzheimer's disease.

Methods, Mediums, And Systems For Testing Fiber Optic Telecommunication Systems

View page
US Patent:
20230062982, Mar 2, 2023
Filed:
Aug 28, 2021
Appl. No.:
17/460182
Inventors:
- Eatontown NJ, US
D. Mark Havens - Wall NJ, US
Robert P. Bellomo - Montclair NJ, US
Bamdad Bakhshi - Asbury Park NJ, US
Robert Behringer - Monmouth Beach NJ, US
Roberto Mattos - Morganville NJ, US
Ying Jiang - Metuchen NJ, US
William C. Barnett - Freehold NJ, US
Mark Enright - Hampton NJ, US
Assignee:
SUBCOM, LLC - Eatontown NJ
International Classification:
H04B 10/07
Abstract:
This application describes techniques for testing fiber optic telecommunication systems, such as undersea fiber optic cable systems. Testing terminals may be deployed at a location of terminating equipment for a fiber optic cable. The testing terminals may be operated remotely. The testing terminals may be configured to programmatically test the cable by loading one or more tests and automatically configure the cable's transmitters and receivers based on predetermined loading schemes selected based on the tests to be performed. The testing terminals may iterate over channels and fiber pairs of the cable and may use back-to-back tests to remove artifacts from test results. Using the described techniques, a cable's channels and fiber pairs can be fully characterized in the amount of time afforded for a typical testing schedule, which was not generally possible using conventional testing.

Additive To Decrease The Pour Point Of Paraffin Inhibitors

View page
US Patent:
20200277526, Sep 3, 2020
Filed:
Dec 4, 2017
Appl. No.:
16/645643
Inventors:
- San Angelo TX, US
Qiang LAN - The Woodlands TX, US
Ying Cong JIANG - Pearland TX, US
Kiran GAWAS - Humble TX, US
Janet L. NGO - Cypress TX, US
International Classification:
C09K 8/524
E21B 37/06
Abstract:
Included are compositions, methods, and systems for producing and using winterized paraffin inhibitor solutions. An example composition comprises a paraffin inhibitor solution; and an additive comprising a first portion and a second portion; wherein the first portion is selected from the functional groups consisting of sulfo, phosphate, phosphonate, ester, carboxyl, hydroxyl, and any combination thereof; wherein the second portion is selected from the functional groups consisting of linear alkyl, branched alkyl, alkyl phenyl, ethoxylated branched alkyl, propoxylated branched alkyl, and any combination thereof.

Isbn (Books And Publications)

Du Dong Jiang Zemin: Jiang Zemin Zhi Dang Zhi Guo Fang Lue Yan Jiu = Read Jiangzemin

View page
Author

Ying Jiang

ISBN #

7507518205

Ying Ying Jiang from Flushing, NY, age ~48 Get Report